Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesCTAR-guided localization may sub for CT for early-stage lung cancerAR-guided localization was noninferior to conventional CT guidance and led to better patient experiences.CTStudy backs LDCT lung cancer screening in SingaporeClinical NewsNew criteria evaluates treatment response in bone metastasesCTCT sign may flag who benefits from subdural hematoma procedureHomeClassification system could improve MRI lumbar spinal stenosis grading
